Nektar Therapeutics R&D chief sells $397,670 of common stock

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Form 13D/A WEREWOLF THERAPEUTICS For: 2 July Hisse Senetleri 0 1
A Form 4 Nektar Therapeutics For: 2 July Hisse Senetleri 0 2
A Form 424B5 Elicio Therapeutics Inc For: 2 July Hisse Senetleri 0 2
A Elicio Therapeutics raises $15M in registered direct offering Hisse Senetleri 0 2
A Nektar Therapeutics reports $741.7 million in cash and investments as of April 1 Hisse Senetleri 0 23
A Nektar presents rezpegaldesleukin data at dermatology meeting Hisse Senetleri 0 20
A Nektar presents rezpegaldesleukin data at dermatology meeting Hisse Senetleri 0 46
A Oppenheimer raises Nektar Therapeutics price target to $140 Hisse Senetleri 0 52

Benzer konular

Üst